Phathom Pharmaceuticals, Inc. (PHAT) Deep Dive Video
Summary
Phathom is a high-risk, high-upside GI disruptor with VOQUEZNA scaling rapidly toward profitability under protected exclusivity through 2032.
View PHAT stock page · Read the PHAT research report
Loading the video player…